Bellerophon Therapeutics, Inc. Restructuring Charges
Bellerophon Therapeutics, Inc. reported Restructuring Charges of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2017-03-13
- Bellerophon Therapeutics, Inc. restructuring charges for fiscal 2015 was $0.00.
| Period end | Restructuring Charges 12 month |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2017-03-13 |